BWX Technologies, Inc. — Q2 2023 Form 10-Q Summary
Business context and reporting period
BWXT reported results for the three and six months ended June 30, 2023. The company operates through Government Operations, which supports U.S. naval nuclear, DOE, defense and advanced nuclear programs, and Commercial Operations, which serves commercial nuclear, Canadian refurbishment and medical isotope markets.
Key financial metrics
| Metric | Q2 2023 | Q2 2022 | Six months 2023 | Six months 2022 |
|---|---|---|---|---|
| Revenue | $612.4 million | $554.2 million | $1.181 billion | $1.085 billion |
| Operating income | $86.7 million | $95.2 million | $174.5 million | $166.8 million |
| Net income attributable to BWXT | $58.6 million | $74.6 million | $119.7 million | $133.6 million |
| Diluted EPS | $0.64 | $0.82 | $1.30 | $1.46 |
| Operating margin | 14.2% | 17.2% | 14.8% | 15.4% |
| Operating cash flow | Not separately provided | Not separately provided | $67.6 million | $72.0 million |
Government Operations revenue increased 12.7% in Q2 and 9.6% for the first six months. Government Operations operating margins were 16.7% in Q2 and 18.2% year to date. Commercial Operations revenue increased 2.0% in Q2 and 5.2% year to date, while margins declined to 9.1% and 5.5%, respectively.
At June 30, 2023, cash and cash equivalents were $33.9 million, restricted cash was $5.7 million in total, and investments were $9.0 million. Total debt was approximately $1.337 billion, including $1.331 billion of long-term debt and $6.3 million of current debt. Working capital was $491.1 million.
The company generated $67.6 million of operating cash flow and used $65.9 million in investing activities, including $69.6 million of capital expenditures. Financing activities used $3.3 million, including $42.7 million of dividends paid. Cash and restricted cash declined by $1.4 million during the first six months.
Material changes versus the prior comparable period
- Revenue rose $58.2 million, or 10.5%, in Q2 and $95.9 million, or 8.8%, year to date, primarily from higher Government Operations volume, advanced technologies work, downblending activity and the prior-year Dynamic Controls and Cunico acquisition.
- Q2 operating income declined $8.6 million despite higher revenue. Government and Commercial Operations operating income decreased by $1.6 million and $1.8 million, respectively, while unallocated corporate expense increased $5.1 million.
- Year-to-date operating income increased $7.7 million, led by a $16.8 million increase in Government Operations, partly offset by a $4.3 million decline in Commercial Operations and a $4.8 million increase in corporate expense.
- Net income attributable to BWXT declined 21.5% in Q2 and 10.4% year to date. Higher interest expense and lower other income were significant contributors. Other income included $9.6 million of Q2 losses from non-designated foreign-exchange forward contracts, compared with a $7.5 million gain in the prior-year quarter.
- Net unfavorable contract estimate changes reduced revenue by $5.2 million in Q2 and $13.0 million year to date. Commercial Operations also incurred $1.4 million of additional restructuring-related expense year to date.
- Backlog was $4.115 billion at June 30, 2023, compared with $4.144 billion at December 31, 2022. Approximately 58% is expected to be recognized by the end of 2024; $483.7 million was unfunded U.S. Government backlog.
Outlook, risks, contingencies and unusual items
The filing does not provide a clear quantitative full-year revenue or earnings guidance range. Management stated that it expects sufficient cash, operating cash flow, borrowing capacity and capital-market access to meet cash requirements for the next 12 months and beyond.
- Government Operations depends substantially on U.S. Government defense spending, annual appropriations and contract performance. Approximately $200 million of unexercised options were excluded from backlog and are subject to annual appropriations.
- Fixed-price contracts expose BWXT to labor, productivity, material-cost and schedule risks. Contract estimates may change materially, and the company is pursuing recovery of cost overruns on a prior Government Operations project.
- A DOE contract awarded to a joint venture in April 2023 was protested and returned to the DOE for reassessment. If re-awarded, transition is expected no earlier than the first half of 2024 and would require significant working-capital contributions during the first year.
- Commercial Operations results are exposed to maintenance-outage timing, Canadian refurbishment activity, nuclear-capital-spending cycles, product mix and medical isotope demand.
- BWXT had $448.3 million available under its $750 million revolving facility, with $300.0 million drawn and $1.7 million of letters of credit outstanding. The Term Loan had $246.9 million outstanding. The weighted-average interest rate on Credit Facility borrowings was 6.73%.
- The company was in compliance with its credit-facility and senior-note covenants. Surety bonds outstanding totaled approximately $114.7 million, and bilateral letters of credit totaled approximately $36.2 million.
- Underfunded pension and postretirement obligations totaled approximately $75.9 million; expected contributions for the remainder of 2023 were approximately $3.9 million.
- Management reported no material contingencies during the period and no material changes to previously disclosed risk factors or internal controls.
Important facts for investors to verify
- Whether Government Operations growth and backlog conversion offset pressure from contract estimate changes, corporate costs and higher interest expense.
- The recoverability and timing of amounts related to the prior Government Operations cost-overrun project.
- Commercial Operations margin recovery as Canadian refurbishment and field-service activity increases.
- U.S. Government appropriations, unfunded backlog and the approximately $200 million of excluded contract options.
- Liquidity, refinancing needs and covenant headroom given approximately $1.337 billion of total debt and variable-rate borrowings.
- The outcome and potential working-capital impact of the protested DOE joint-venture contract.
- Foreign-exchange exposure, including $479.0 million of FX-forward notional value and the volatility of non-designated hedge gains and losses.